HLA-G and B-cell chronic lymphocytic leukemia: Of note, ours is not the first study to observe this strong role of β2-microglobulin in predicting outcome in this particular early-stage CLL subset.23, 44 The reason why a significant proportion of patients show high β2-microglobuline levels in the context of a low CLL burden disease still remains unclear.